We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Vortioxetine hydrobromide

Australian Public Assessment Report

AusPAR

AusPAR: Vortioxetine hydrobromide [PDF, 1.47 MB]

AusPAR: Vortioxetine hydrobromide [DOCX, 3.49 MB]

Attachment: Product Information: Vortioxetine hydrobromide [PDF, 290 KB]

Attachment: Product Information: Vortioxetine hydrobromide [DOCX, 106.09 KB]

Attachment: Extract from Clinical Evaluation Report: Vortioxetine hydrobromide [PDF, 2.03 MB]

Attachment: Extract from Clinical Evaluation Report: Vortioxetine hydrobromide [DOCX, 4.83 MB]

Device/Product Name

Brintellix

Active ingredients

Vortioxetine hydrobromide

AusPAR Date

8 July 2014

Published

4 August 2014

Submission Number

PM-2012-03463-1-1

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines